AMED SALAH 4
4 · BARR PHARMACEUTICALS INC · Filed Jan 10, 2006
Insider Transaction Report
Form 4
AMED SALAH
Sr.VP, R&D
Transactions
- Sale
Common Stock
2006-01-09$66.54/sh−4,804$319,635→ 135,436.96 total - Exercise of In-Money
Common Stock
2006-01-10$11.06/sh+45,800$506,649→ 181,236.96 total - Sale
Common Stock
2006-01-10$66.62/sh−45,800$3,051,301→ 135,436.96 total - Exercise of In-Money
Non-Qualified Stock Options
2006-01-10$11.06/sh−45,800$506,649→ 267,473 totalExercise: $11.06From: 2001-10-24Exp: 2009-08-11→ Common Stock (45,800 underlying) - Exercise of In-Money
Common Stock
2006-01-09$11.06/sh+4,804$53,143→ 140,240.96 total - Exercise of In-Money
Non-Qualified Stock Options
2006-01-09$11.06/sh−4,804$53,143→ 313,273 totalExercise: $11.06From: 2001-10-24Exp: 2009-08-11→ Common Stock (4,804 underlying)